| Financial Year |
March 31 2023 |
| Monetary Funds |
3,619,956,951.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
6,263,214.26 |
| Advances to Suppliers |
317,921,100.37 |
| Other Receivables |
16,534,325.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,811,381,562.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
159,016,856.63 |
| Total Current Assets |
7,447,350,654.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,745,127.65 |
| Investment Properties |
-- |
| Fixed Assetes |
8,721,400,125.36 |
| Under-construction Projects |
354,822,053.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
508,756,236.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
405,833,990.40 |
| Other Non-Current Assets |
265,254,594.00 |
| Sub-Total of Non-Current Assets |
10,585,348,489.08 |
| Total Assets |
18,032,699,143.49 |
| Short-Term Loans |
959,858,282.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,702,036,754.42 |
| Accounts Payable |
1,679,770,298.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,030,621.86 |
| Taxes Payable |
13,703,294.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
275,739,613.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
291,598,258.78 |
| Other Current Liabilities |
70,251,516.44 |
| Sub-Total of Current Liabilities |
8,544,386,897.06 |
| Long-term Loans |
615,822,197.11 |
| Bonds Payable |
196,114,605.50 |
| Long-Term Accounts Payable |
198,732,018.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,629,899.40 |
| Deferred Income Tax Liabilities |
174,830,269.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,293,442,943.20 |
| Total Liabilities |
9,837,829,840.26 |
| Paid-In Capital(Or Share Stock) |
2,852,155,097.00 |
| Capital Surplus |
601,107,383.00 |
| Surplus Reserve |
992,916,348.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,609,815,218.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,194,869,303.23 |
| Owner's Equity（Stockholder's Equity） |
8,194,869,303.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,032,699,143.49 |
